| |
|
|
|
Solid Biosciences Inc  
|
|
2.45 -0.75 (-0.23%) |
09-28 16:00 |
|
Open: |
2.61 |
Pre close: |
3.2 |
Target:
|
3.56 
|
|
High: |
2.61 |
Low: |
2.45 |
Resistance:
|
3.05
3.42
|
|
Volume: |
1,393,995 |
Market Cap: |
270M |
Support:
|
2.45
2.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.74
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
2.75 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
3.26 |
Stochastic Oscillator |
%K(14,3):
|
7.87 |
|
MA(250): |
4.69  |
%D(3): |
23.60 |
|
Average Volume(K) |
3-Month: |
1614957
|
52-Week |
High:
|
11.58 |
|
10-Days: |
308829 |
Low: |
2.37 |
|
RSI |
RSI(14):
|
40.21 |
Change(%): |
20.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.261 |
Return on Equity (ttm) |
-56.1 |
Shares Out. (M) |
110.30 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-30.2 |
Shares Float (M) |
41.48 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.91 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
73.67 |
|
Forward EPS |
-2.910 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
6550 |
|
Book Value (p.s.) |
2.290 |
EBITDA (p.s.) |
-0.681 |
P/E |
-1.94 |
|
Sales Per Share |
0.063 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-52.72 |
P/S |
38.99 |
|
Operating Margin |
-1127.78 |
Levered Free Cash Flow
(M) |
-27.87 |
P/CF |
-5.13 |
|
|
|
|
|
|
